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Abstract Objective: To study the
phenomenology, clinical correlates,
and response to treatment of delirium
in critically ill childrenin the pediatric
intensive care unit (PICU). Design,
setting and patients: Descriptive
study of a cohort of child psychiatric
consultations from a tertiary PICU
between January 2002 and December
2005. Demographic data, clinical pre-
sentation, and response to treatment
of children subsequently diagnosed
with delirium were analyzed. Re-
sults: Out of 877 admissions (age
distribution 0–18 years) arose 61
requests for psychiatric assessment.
Of the 61 children, 40 (15 girls and 25
boys) were diagnosed with delirium
(cumulative incidence 5%; mean age
7.6 years). Age-speciﬁc incidence
rates varied from 3% (0–3 years) to
19% (16–18 years). In addition to the
classical hypoactive and hyperactive
presentations, a third presentation
was apparent, characterized mainly
by anxiety, with a higher prevalence
in boys. All but 2 of the 40 children
received antipsychotic medication:
27 (68%) haloperidol, 10 (25%)
risperidone, and 1 both in succession.
Two children treated with haloperidol
experiencedan acute torticollis asside
effect. All children made a complete
recoveryfrom the delirium; ﬁve, how-
ever, died of their underlying disease.
Conclusion: The rate of delirium in
critically ill children on a PICU is not
negligible, yet prospective studies of
the phenomenology, risk factors and
treatment of childhood delirium are
very rare. Once pediatric delirium
has been recognized, it generally
responds well to treatment.
Keywords Delirium · Critically ill
children · Pediatric intensive care
unit (PICU) · Consensus meetings ·
Haloperidol · Risperidone
Introduction
Delirium is a neuropsychiatric disorder secondary to
a general medical condition, and must be considered
a serious complication of the underlying disease or its
treatment. In the revised fourth edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV-
TR®), delirium is deﬁned by four concurrent diagnostic
criteria: (1) acute onset and ﬂuctuation of (2) a disturbance
of consciousness with reduced ability to focus, shift or
maintain attention and (3) a change of cognition with
memory deﬁcit, disorientation, language disturbance,
perceptual disturbances or hallucinations, (4) caused
by the direct physiological consequences of a general
medical condition [1]. It is frequently seen in critically ill
adult and geriatric patients [2–5] and is associated with
a poor prognosis, reﬂected by longer hospital stay, worse
functional and cognitive outcome, and a higher mortality1034
rate after discharge from hospital [3]. In mechanically
ventilated critically ill adults, delirium is an independent
predictor of elevated 6-month mortality and a longer
hospital stay [6]. If appropriate diagnostic tools validated
for bedside use by non-psychiatrists [e.g. Delirium Rating
Scale (DRS), Confusion Assessment Instrument for the
Intensive Care Unit (CAM-ICU)] are used, delirium is
diagnosed in over 80% of critically ill adult patients [7].
Thus, systematic monitoring for delirium and appropriate
treatment with haloperidol in critically ill adult patients
were included in the recently published clinical practice
guidelines for sedatives and analgesia of the Society
of Critical Care Medicine [8]. However, the optimal
management of patients with delirium and the effects of
the pharmacological treatment on the outcome are still
key concerns for today [9]. Given lack of age-appropriate
diagnostic criteria and assessment tools in children, even
less is known about the incidence, clinical presentation,
response to treatment and consequences of childhood
delirium in general, and in critically ill children in par-
ticular [10–12]. The few available published data on
childhood delirium suggest that morbidity and mortality
are higher in children with than in children without
delirium [13]. Therefore, delirium in children should
be considered a serious complication and be treated
accordingly. Unfortunately, while there are comprehensive
guidelines on the diagnosis and treatment of delirium
in adults, clinical guidelines for delirium in children are
nonexistent.
The aim of this study was to investigate the incidence,
patient andpopulationcharacteristics,clinical presentation
and response to treatment of delirium in a cohort of crit-
ically ill children admitted to a tertiary pediatric intensive
care unit (PICU). Given the necessarily multidisciplinary
approachtoassessmentandtreatmentofthesechildren,the
input of four disciplines – child psychiatry, pediatric inten-
sive care medicine, child neurology and adult neuropsych-
iatry – was used.
Methods
Design, setting and patients
A descriptive study was carried out over a 4-year period
(January 2002 to December 2005) in an eight-bed tertiary
PICU. This PICU is a tertiary referral center for both gen-
eral and surgically critically ill children in the southeast-
ern region of the Netherlands (population 1.4 million, 350
annual admissions). Critically ill children, acutely, non-
electively and consecutively admitted, were prospectively
sampled. Both mechanically ventilated and non-ventilated
patients were included.
Diagnostic approach
All children with (1) confusion, agitation, anxiety,
moaning, discomfort, or behavioral disturbances with no
acceptable medical explanation or (2) failure of standard
analgosedative treatment were systematically assessed
for the presence of delirium in a two-step diagnostic
approach. The standard analgosedative treatment can be
summarized as follows: children who required analgose-
dation because of obvious or expected pain or because of
stress related to their underlying disease or treatment re-
ceived adequate doses of opioids and/or benzodiazepines
according to internationally published guidelines for
analgesia and sedation in critically ill children [14].
Drug doses were individually tailored to achieve optimal
patient comfort and were slowly reduced in order to avoid
a withdrawal syndrome. In the event that a withdrawal
syndrome was suspected, based on clinical observation
or the revised Finnegan score, speciﬁc treatment with
long-acting benzodiazepines (e.g. lorazepam) or opioids
(e.g. methadone) was started according to internationally
published guidelines [15, 16].
At the time the assessment for delirium was initiated,
none of the patients had signs of imminent life-threatening
respiratory,circulatoryor neurologicalfailure,while ongo-
ing asphyxia, respiratory acidosis, metabolic disturbances,
ﬁghting the ventilator due to inappropriate ventilator set-
tings and withdrawal syndrome all had been excluded sys-
tematically as an explanation for the observed behavior.
The ﬁrst step of the diagnostic approach was a sys-
tematic assessment by a child neuropsychiatrist (J.S.)
using DSM-IV criteria for delirium. Criteria were eval-
uated on the basis of (1) hetero-anamnestic information
from parents, nurses, intensivists, and child neurologists
about behavior and behavioral changes and (2) child
psychiatric examination. Based on the ﬁndings, patients
were categorized as having a (probable) delirium or not.
In a second step, the provisional diagnosis of delirium
was further tested in a daily multidisciplinary consensus
meeting. The team consisted of the child neuropsychia-
trist, the attending pediatric intensivist, and occasionally
a geriatric neuropsychiatrist specialized in delirium
in geriatric patients and/or a child neurologist. If this
team agreed that alternative explanations for a child’s
behavior were unlikely, the consensus diagnosis was
delirium.
Based on the dominant clinical presentation, cases
of delirium were classiﬁed as “hyperactive” when psy-
chomotor agitation was present, and as “hypoactive”
when retardation and/or inhibition was present. A number
of children presented with cognitive and/or attentional
disturbances in the context of severe anxiety states,
often accompanied with moaning and restlessness, but1035
without clear agitation or retardation. This latter group
was classiﬁed as “emerging” or “veiled” delirium [17],
in reference to the way delirious syndromes have been
described as “partial delirium” in adult ICU patients or as
“subsyndromal delirium” in elderly medical patients [7,
18, 19]. The different presentation forms were not always
clear-cut, and some ﬂuctuated dramatically over time. The
severity of illness was scored according to the Pediatric
Index of Mortality (PIM) and Pediatric Risk of Mortality
(PRISM) [20].
Therapeutic approach
Whenever delirium was identiﬁed or suspected, a two-
track treatment approach consisting of both psychosocial
and pharmacological interventions was implemented.
Psychosocial interventions – the parents’ presence and
comforting throughoutthe day (and night), familiar music,
favorite toys, pictures of home and pets, friends, school,
lighting schedules, sometimes even fragrances – are
standard in the PICU. The parents also received an in-
formation leaﬂet on childhood delirium [21]. All patients
were also treated with antipsychotic medication after the
referring pediatric intensivist had agreed and the parents,
because of the off-label use, had given informed consent,
which was never refused. In children with psychomotor
agitation that was acutely threatening to their health
status, haloperidol at a loading dosage of 0.15–0.25 mg
i.v. was used, given slowly over a period of 30–45 min,
followed by a maintenance dose of 0.05–0.5 mg/kg/24h
i.v. [11, 22, 23]. In less acute situations, and when oral
medication was possible, risperidone at a loading dose
of 0.1–0.2 mg p.o. was used, followed by a maintenance
dose of 0.2–2.0 mg/24h p.o. as the treatment of choice.
Clinical response and side effects were recorded by the
child neuropsychiatrist and the pediatric intensivists. In
order to tailor the treatment for delirium, daily discussions
Fig.1 Incidence of delirium in
the sub-groups by age and
gender
were held with the multidisciplinary team. Adjustment
of treatment was based on the clinical observations and
judgements of the parents, nurses, intensivists and child
psychiatrist.
Children were followed up for 6 weeks after discharge
from the hospital either at the outpatient clinic or by con-
tacting the parents by telephone.
As the study solely involvedthe structuredrecording of
routine clinical practice, under Dutch law no institutional
review board approval was required.
Table 1 Number and incidence of delirium in the total sample∗ by
age and gender
Age Total Patients Incidence
sample∗ with delirium (%)
0–2.99 years 513 14 2.7
Male 310 9 2.9
Female 203 5 2.5
3–5.99 years 106 4 3.8
Male 56 3 5.4
Female 50 1 2.0
6–8.99 years 80 6 7.5
Male 46 1 2.2
Female 34 5 14.7
9–11.99 years 77 3 3.9
Male 61 3 4.9
Female 16 0 0
12–14.99 years 70 7 10
Male 35 5 14.3
Female 35 2 5.7
15–18 years 31 6 19.4
Male 13 4 30.8
Female 18 2 11.1
Total 877 40 4.6
Male 521 25 4.8
Female 356 15 4.2
∗Critically ill children, acutely, non-electively and consecutively ad-
mitted during a 4-year period1036
Table 2 Child psychiatric diagnosis at the ﬁrst consultation (n=61)
n Diagnosis
40 delirium
5 adjustment disorders with anxiety and
depressed mood, post operative
4 psychological–psychiatric factors
affecting the medical condition
3 anxiety disorder
3 emotional and behavioral problems
during chronic ventilation
2 adjustment disorders with depressed mood
1 mood disorder
1 adjustment disorder with anxiety
1 sleeping problem
1 feeding problem
Table 3 Population characteristics of the 40 PICU cases with delir-
ium, 2002–2005
Characteristics Frequency
(total n=40)
Age (mean±SD) 7.6±5.9
Male
n 25
age (mean±SD) 7.6±6.1
Female
n 15
age (mean±SD) 7.6±5.8
Ethnicity
White 36 (90%)
African 3 (7.5%)
Asian 1 (2.5%)
Mechanical ventilation 34 (85%)
PIM score (mean±SD) 9.96±16.20
PRISM score (mean±SD) 23.54±24.94
Major somatic pharmacological
features
Recent increase or decrease of
analgosedative medication 22 (55%)
Neurological disorders 21 (52%)
Infectious disorders 20 (50%)
Respiratory disorders 12 (30%)
PIM, Pediatric Index of Mortality; PRISM, Pediatric Risk of Mortal-
ity
Results
From January 2002 to December 2005, there were 877
acute, non-elective admissions to the PICU. Distribution
of age and gender are shown in Table1. In 61 cases (7%),
a systematic assessment by a child neuropsychiatrist
was requested, usually for agitation, anxiety, moan-
ing, discomfort, behavioral disturbance or problematic
analgosedation.
Of these 61 patients, 40 (61%) were diagnosed with
delirium, yielding a cumulativeincidenceof 5% (boys5%;
girls 4%). Age-speciﬁc incidences increased from 3% in
the 0–3 years age group (boys 3%; girls 3%), to 19% in
the 16–18years age group (boys 31%;girls 11%) (Table1,
Fig.1).
The child psychiatric disorders diagnosed in the 61 re-
ferrals are summarized in Table2.
Table3 summarizes the population characteristics of
the sample diagnosedwith delirium, while Table4 lists the
underlying somatic disease or causative pharmacological
treatment.
The underlying features were: recent increase or de-
crease in analgosedative medication (n= 22), neurological
disorders (n= 21), infections (n= 20) and respiratory dis-
orders (n= 12). Usually, a combination of these existed.
All but two patients were treated with an antipsychotic
drug. Twenty-seven children were given haloperidol, 10
risperidone, and 1 child received both drugs in succession.
In most cases, the beneﬁcial results were observed rapidly,
especially in the hyperactive forms, sometimes even after
a single dose [11]. Sometimes it took a few hours or days.
Two patients experienced acute dystonia as a likely side
effect of the haloperidol, responding well to biperidene.
Two children received no medication: one because of lack
of consensus in our expert team, and one because of an
endotrachealintubation at the time that medication was in-
dicated. In most cases, the medication was stopped or ta-
pered off successfully during hospitalization or afterwards
in an outpatient setting. Five children (12.5%) with delir-
ium died of their underlying disease; the mean PIM was
10% and the mean PRISM 24% (Table3).
Discussion
This is the ﬁrst systematic multidisciplinary study of the
phenomenology and treatment of delirium in 40 critically
ill children in a PICU context. The low cumulative inci-
denceof 5%is mainly the resultof the low incidencein the
youngeragegroups(<9 yearsold),thissegmentconstitut-
ing themajorityofthetotal sample(80%).A clearlyhigher
incidence is seen in the older age groups. However, in crit-
ically ill adult patientssubstantially higherincidenceshave
been reported, ranging from 10–30% in general hospital
settings to 50% in postoperative patients and up to 80% in
the terminally ill [2].
There are several possible explanations for this differ-
ence. First, the incidence of delirium in young critically
ill children may be truly low: differences in age-related
resilience and underlying conditions may contribute to
true differences in the incidence between the very young
and the very old. Howeverthis explanationseems unlikely,
given the tendency in the very young to develop delirium
under even much less severe circumstances [1, 11, 24].
A second explanation may relate to the fact that extensive
psychosocial interventions are provided as a routine in
Dutch PICU settings, with a possibly preventive effect on
delirium in much the same way as observed in geriatric
patients [25]. A third factor may be an anti-delirium1037
Table 4 Patient characteristics of the 40 PICU cases with delirium 2002–2005
No. Sex Age Primary diagnosis on admission PICU Mechanical Delirium Treatment
ventilation type
1 M 3 months Multiple congenital malformations + Emerging Haloperidol
2 F 4 months Meningococcal septic shock + Emerging Risperidone
3 M 4.5 months Severe CLD + Emerging Risperidone
4 F 10 months Near drowning + Emerging Haloperidol
5 F 1 year Pneumonia + Emerging Haloperidol
6 M 1 year Sepsis due to perforated appendicitis + Emerging Haloperidol
7 M 1 year Subarachnoid bleeding + Emerging Haloperidol
8 M 1 year Pericardial effusion with pretamponade + Hyperactive Haloperidol
9 M 1 year Multiple dysmorphia, upper airway obstruction – Emerging Haloperidol
10 F 2 years Meningococcal septic shock + Hyperactive Haloperidol
11 M 2 years ADEM + Hyperactive Risperidone
12 M 2 years Cervical mass, upper airway obstruction + Emerging Haloperidol
13 M 2 years Aspiration and pneumothorax + Hypoactive –
14 F 2 years Meningococcal meningitis with sepsis and DIC + Hyperactive Haloperidol
15 F 3 years Cystic ﬁbrosis and pneumonia + Hypoactive Haloperidol
16 M 4 years Intracerebral hemorrhage, Marfan syndrome + Hypoactive Haloperidol
17 M 5 years Medulloblastoma post surgery + Emerging Risperidone
18 M 5 years Upper respiratory tract infection + Hyperactive Haloperidol
19 M 6 years Multiple trauma + Emerging Risperidone
20 F 8 years Meningo-encephalitis + Hyperactive Risperidone
21 F 8 years Viral encephalitis + Hyperactive –
22 F 9 years Status asthmaticus + Hyperactive Risperidone
23 F 9 years TBI, gunshot wound + Hypoactive Risperidone
24 M 9 years Status asthmaticus + Hyperactive Haloperidol
25 M 9 years Neural tube defect and drain dysfunction – Emerging ﬁrst Haloperidol,
then Risperidone
26 M 11 years Hypovolemic shock, typhus abdominalis – Hyperactive Haloperidol
27 F 12 years TBI + Hypoactive Haloperidol
28 M 12 years TBI and fracture of lower leg + Emerging Haloperidol
29 M 13 years Sepsis, paronychia – Hyperactive Haloperidol
30 M 13 years Status epilepticus + Emerging Haloperidol
31 F 14 years TBI + Hyperactive Haloperidol
32 F 15 years Post TBI + Hypoactive Haloperidol
33 M 15 years Postoperative state + Hypoactive Risperidone
34 M 15 years Acute lymphoblastic leukemia – Hypoactive Haloperidol
35 M 15 years TBI + Emerging Haloperidol
36 F 15 years Status asthmaticus + Hyperactive Haloperidol
37 M 16 years Multiple trauma – Hypoactive Haloperidol
38 F 16 years Bacterial meningitis + Hyperactive Risperidone
39 M 16 years Respiratory failure, Duchenne disease + Emerging Haloperidol
40 M 17 years Septic shock + Emerging Haloperidol
CLD, chronic lung disease; ADEM, acute disseminated encephalomyelitis; DIC, diffuse intravascular coagulation; TBI, traumatic brain
injury
effect of the routinely used analgosedative medication,
although especially benzodiazepines may have excitatory
side effects in children. A fourth factor may relate to
reluctance on the part of the intensivists and/or child
neurologists to request psychiatric evaluation in the case
of behavioral changes for fear of adding stigmatization
to an already burdened system. Perhaps the ﬁfth, most
likely and important explanation is that parents, nurses,
pediatric intensivists and child neurologists do not easily
recognize delirium, because the medical condition of these
critically ill PICU children is so complex and changeable.
It is possible that a psychiatric consultation was readily
requested only in cases of anxiety and/or hyperactive
delirium, not in the hypoactive and or veiled ones.
The differential diagnosis of pediatric delirium con-
sists of acute stress reactions, acute anxiety states, adjust-
ment disorders with mixed emotions, dissociative and/or
regressive states and childhood-onset psychosis (see also
Table2). However, differentiating delirium from extreme
stress and agitation due to acute and life-threatening con-
ditions is not only impossible, it is also unwanted, because
it is usually irrelevant at that point of time in the process of
medical care. Causative treatment, if possible, is always
the ﬁrst step to be taken. Furthermore, the diagnosis of
delirium in children is complicated by the fact that the cri-
teria for adult delirium are not always easily applicable to
children because of important differences in age and de-
velopmental levels. The DSM-IV criteria for delirium are1038
not always useful in the case of pediatric delirium, espe-
ciallyinaPICUcontext.Thisisasourceofconcern.More-
over, delirium is not mentioned in the DSM-IV section on
child psychiatry. DSM-IV describes as an essential feature
of delirium the “disturbance of consciousness” leading to
“impairment of the ability to focus, shift and sustain atten-
tion”.This,however,isoflittle relevancein thecritically ill
in a PICU context, where disturbance of attention is rou-
tinely present due to the disorder(s) itself. In fact, atten-
tion is often the ﬁrst “to go” [17, 26]. In addition, patients
almost always require treatment with opioids and benzo-
diazepines, which also have a strong impact on attention.
Furthermore, it has been hypothesized that a disturbance
of consciousness is not a discriminating characteristic of
delirium in an ICU setting [27].
Our case series suggests that in addition to the hyper-
and hypoactive forms of delirium, a third form may be
characterized by anxiety, moaning, and/or restlessness.
This was referred to as an “emerging” or veiled delirium,
as described previously [17]. In the PICU population this
state did not develop into a frank hyper- or hypoactive
form, but appeared to exist in its own right, accompanied
by disturbances of consciousness and cognition.
Although atypical presentations of disorders are often
not captured in classiﬁcation systems, the high prevalence
of “emerging” delirium in our sample (17/40) stresses the
importance of further phenomenological study. Adhering
toostronglytoDSM-IV criteriaforadultdelirium,forclin-
ical use in a PICU context, may result in persistent under-
diagnosis. On the other hand, the incidence of delirium
may be overestimatedby usingthe CAM-ICU, so most im-
portant is the issue of what constitutes delirium in critical
illness [28].
There are accumulating indications that pediatric delir-
ium can be subtle and accompanied or even dominated
by other neuropsychiatric signs such as: reduction of
awareness of the caregiver and/or the surrounding envi-
ronment, purposeless actions, restlessness, inconsolability,
signs of autonomic dysregulation and other subtle higher
cortical dysfunctions [29–32]. Parents and nurses have
a way of discriminating patterns in their children that
may be diagnostically important. Thus, parents sometimes
state: “This is not my child anymore.” Pediatric delirium
therefore may have various subtle presentations and
can be considered a spectrum disorder, which makes it
sometimes difﬁcult to diagnose [33]. Neither haloperidol
nor risperidone is registered for the treatment of childhood
delirium, although both are mentioned as the treatment
of choice for adults [1]. Moreover, haloperidol is not
registered for i.v. administration, even though it is used
in this way in many places. We prefer risperidone in
non-acute situations because of the theoretically lower
risk of extrapyramidal side effects. Haloperidol and
risperidone have been used for other indications in young
children as well, such as childhood psychosis [34] or
aggression in autism [35]. There are two limitations
regarding our observations of treatment response. First,
no severity scale for pediatric delirium was used, because
none exists for this PICU population. Second, because no
studies on the natural course of childhood delirium exist
that have established the rate of spontaneous remission,
spontaneous remissions may have been misclassiﬁed
as response to treatment. In our opinion, however, the
time frame of response points towards a medication
effect.
Most medications employed in pediatrics and child
psychiatry are used off-label [36], which means that spe-
cial attention should be paid to information and informed
consent procedures. Given the relatively high incidence of
extrapyramidalsymptomswith haloperidol,the “off-label”
use needs further study [37].
This study has several limitations. First, it was a study
of routine clinical practice. Observations were based on
referrals emerging from care as usual. Although the focus
on delirium may have altered referral paths and rates, we
did not actively advocateany change,nor did we screen all
admissions for delirium. In the absence of a hard clinical
indication, no routine blood level measurements were
performed to rule out persistent high levels of sedatives as
a possible explanation for any neuropsychiatric symptom.
Next, the lack of DSM-IV criteria for pediatric delirium
and the disputed relevance of its main criterion in a (P)ICU
setting make a standardized diagnosis difﬁcult. Finally,
treatment was provided in an open setting and based on
consensus, especially among child psychiatrist, pediatric
intensivist and child neurologist.
In conclusion, critically ill children in a PICU can
develop delirium, with a hyperactive, hypoactive or
veiled presentation, despite adequate analgosedation
and intensive psychosocial interventions. The approach
using an algorithmic structuring and an intensifying
of daily clinical care, including the use of multidisci-
plinary daily consensus meetings, appeared effective in
assessing, diagnosing and treating childhood delirium
at the PICU. The ﬁndings suggest that the incidence is
much lower than in adults, but a likely explanation is
that delirious states requiring child psychiatric referral
are still frequently under-diagnosed. There is also still
a great need for developing delirium criteria in critically
ill patients, children and adults alike, in a (P)ICU setting.
Treatment with haloperidol or risperidone was successful
in all patients. Future research is necessary to identify
the risk factors for pediatric delirium in a multivariate
prospective approach, to develop “easy to use” bedside
tools for non-psychiatric trained team members for the
early detection of delirium in all pediatric PICU patients,
and to study the effects of interventions in a double-blind
and ideally placebo-controlled fashion.1039
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